Skip to content

Evaluation of the effect of Modafinil on consciousness in patients with brain damage in Intensive care unit

Evaluation of the effect of Modafinil on consciousness in patients with brain damage in Intensive care unit

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141209020258N190
Enrollment
126
Registered
2023-10-12
Start date
2023-10-23
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain damage. Other specified brain damage due to birth injury

Interventions

Intervention 1: Intervention group: Modafinil drug will be administered orally or by gavage in the amount of 100 mg twice a day. Intervention 2: Control group: will receive placebo twice a day.

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 50 Years

Inclusion criteria

Inclusion criteria: GCS less than 10 Intubation Between 16 and 50 years History of brain injury Absence of space-occupying lesion in brain CT scan (hematoma, tumor) No history of seizures No addiction to psychoactive substances and narcotics No history of hypertension, ischemic heart disease and diabetes mellitus Heart rate less than 120 beats per minute

Exclusion criteria

Exclusion criteria: arrhythmia Emergence of evidence of drug sensitivity Death Lack of consent of the patient to participate in the study

Design outcomes

Primary

MeasureTime frame
Time required until ventilator isolation. Timepoint: End of study. Method of measurement: Clinical observation.;Level of consciousness. Timepoint: On consecutive days from the first day of hospitalization to the day of discharge. Method of measurement: Glasgow coma scale.;Agitation intensity. Timepoint: On consecutive days from the first day of hospitalization to the day of discharge from the intensive care unit. Method of measurement: Richmond Agitation Sedation Score.;Mortality. Timepoint: End of study. Method of measurement: Clinical observation.;The number of days of hospitalization in the intensive care unit. Timepoint: End of study. Method of measurement: Clinical observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hesamedin Modir

Arak University of Medical Sciences

modir.he@gmail.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026